Family Medicine · Kansas City, KS
NPI
1063572493
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8101 Parallel Pkwy Ste 100
Kansas City, KS, 66112
Phone (913) 299-9200
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,675 services
Medicare patients, 2024
200
Average age 73
Drug cost, 2024
$1.2M
14,238 prescriptions
Company payments, 2025
$819
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael M Parra was code 99214 (office e&m - established), 394 times for 183 patients. In total Michael M Parra billed 1,675 services in 40 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 394 | 183 | $69.61 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 219 | 118 | $10.84 | $2,373 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 118 | 118 | $119.82 | $14K |
| G0008 Administration of influenza virus vaccine | Office | 32 | 31 | $29.94 | $958 |
| 99213 Office E&M - Established | Office | 23 | 19 | $52.62 | $1,210 |
| 90653 Vaccine Product | Office | 22 | 22 | $81.82 | $1,800 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 18 | 15 | $38.81 | $699 |
| 81003 Clinical Chemistry | Office | 17 | 16 | $2.20 | $37.4 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 13 | 13 | $152.74 | $1,986 |
By year: 2022 $54K for 1,398 services; 2023 $68K for 1,029 services; 2024 $60K for 1,675 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 17 | 16 | $2.20 | $37.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael M Parra prescribed most often to Medicare patients was Atorvastatin Calcium, with 562 prescriptions and refills. In total Michael M Parra wrote 14,238 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 562 | 1,514 | 161 | $5,753 |
| Amlodipine Besylate Generic | 556 | 1,502 | 171 | $3,091 |
| Metformin Hcl Generic | 429 | 1,199 | 122 | $3,488 |
| Lisinopril Generic | 422 | 1,106 | 110 | $3,012 |
| Levothyroxine Sodium Generic | 404 | 1,007 | 93 | $4,749 |
| Rosuvastatin Calcium Generic | 402 | 1,106 | 115 | $4,237 |
| Gabapentin Generic | 313 | 545 | 84 | $4,946 |
| Pantoprazole Sodium Generic | 310 | 783 | 94 | $3,874 |
| Alprazolam Generic | 309 | 327 | 62 | $1,396 |
| Metoprolol Succinate Generic | 307 | 861 | 89 | $3,831 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 283 | 333 | 84 | $6,936 |
| Losartan Potassium Generic | 269 | 802 | 83 | $2,240 |
| Omeprazole Generic | 240 | 679 | 61 | $4,103 |
| Prednisone Generic | 227 | 250 | 156 | $569 |
| Hydrochlorothiazide Generic | 222 | 630 | 75 | $1,188 |
Brand drugs: 1,734 claims; generic drugs: 12,421 claims; opioid claims: 572.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael M Parra $819 ($819 in general payments such as food, travel and fees) from 21 companies. The largest payer was Ardelyx, Inc. with $92.49.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 4 | $92.49 |
| Lilly USA, LLC LLY | 4 | $89.6 |
| Astellas Pharma US Inc 4503.T | 4 | $71.8 |
| Amgen Inc. AMGN | 4 | $67.7 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $63.96 |
| Pfizer Inc. PFE | 3 | $51.88 |
| Abbott Laboratories ABT | 2 | $48.81 |
| Novo Nordisk Inc NVO | 3 | $46.36 |
| GlaxoSmithKline, LLC. GSK | 2 | $42.2 |
| Xeris Pharmaceuticals, Inc. | 2 | $33.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.